Omnicell, Inc. today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA.
MOUNTAIN VIEW, Calif., Dec. 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA.
Date: Wednesday, January 9, 2019
Time: 05:00 p.m. PT
Location: Westin St. Francis Hotel, San Francisco, CA
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/communications/events-presentations
Following the conference, a replay of the audio-webcast will be archived for 90 days on the Omnicell website.
About Omnicell
Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company’s autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.
Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 5,000 facilities worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.
Omnicell’s innovative medication adherence solutions, used by over 40,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL-E
View original content to download multimedia:http://www.prnewswire.com/news-releases/omnicell-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300770839.html
SOURCE Omnicell, Inc.
Company Codes: NASDAQ-NMS:OMCL
